NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/30/2026
Back to search
Official data from USPTO
CONCEPT TO CURE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CONCEPT TO CURE
ST13
US500000099297308Class
40, 42
Filing
99297308
Registration
8321033
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
06/30/2026
Trademark type
Word
Nice classes
40, 42
Filing date
07/22/2025
Registration date
06/30/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/30/2026
Last transaction
06/30/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
06/30/2025
First use in commerce
07/18/2025
Drawing code
4
Owner type
03
Owner location
Fort Worth, TX, US
Examiner
HESIK, APRIL ANNE
Law office
N60
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
S&B Industry Inc.
Representatives
S&B Industry Inc.
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Contract manufacturing services for others in the field of medical devicesdiagnostic instrumentslife science equipmentprinted circuit board assemblyprecision machininginjection molding of plasticelectromechanical and fluidic system integration in connection with the contract manufacture for others of medical devicesdiagnostic instrumentslife science equipment
Class 42
Designengineeringresearchdevelopment and testing services in the field of polymeric materialspolymer synthesismaterials customization for medicalscientifictechnological applications; Research and development in the field of Cell Therapy; Research and development in the field of genomics-proteomics; Research and development in the field of medical imaging; Research and development in the field of RUO and diagnostic consumables in the nature of devicescartridgescassettesflow cells; Design and development of software for machine learning; Design and development of artificial intelligence (AI) software; Custom design and development of chemical reagents and biochemical assays; Design and development of software and hardware for research-use-only (RUO) and regulated in vitro diagnostic (IVD) instrumentsmedical devicesassociated consumables in the nature of reagent cartridgesflow cellsdisposable cassettes; engineering services for instrument controlworkflow automationfluidicsthermal systemssoftware for life sciences and biotechnology applications.; Product design and development in the field of research-use-only (RUO) and regulated in vitro diagnostic (IVD) instrumentsmedical devicesassociated consumablesincluding reagent cartridgesflow cellsdisposable cassettes; Research and development in the field of biotechnologylife sciencesmolecular diagnosticsmedical devicesin vitro diagnosticslaboratory automationmicrofluidic devicesinstrument control softwarefluid handling systemsthermal control systemsrobotic systemssensor technologywireless communication
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/30/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/12/2026
PUBO
PUBLISHED FOR OPPOSITION
05/12/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/06/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/14/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/09/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/09/2026
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/09/2026
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/08/2026
GNFR
FINAL REFUSAL E-MAILED
03/08/2026
CNFR
FINAL REFUSAL WRITTEN
03/08/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/02/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/02/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/02/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/13/2025
GNRT
NON-FINAL ACTION E-MAILED
12/13/2025
CNRT
NON-FINAL ACTION WRITTEN
12/13/2025
DOCK
ASSIGNED TO EXAMINER
12/09/2025
MAFR
APPLICATION FILING RECEIPT MAILED
07/22/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/22/2025
NWAP
NEW APPLICATION ENTERED
07/22/2025
Continuous trademark protection
Get notified about every new filing that threatens CONCEPT TO CURE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.